FR2960780B1 - Medicament pour le traitement de la maladie de parkinson - Google Patents

Medicament pour le traitement de la maladie de parkinson

Info

Publication number
FR2960780B1
FR2960780B1 FR1002404A FR1002404A FR2960780B1 FR 2960780 B1 FR2960780 B1 FR 2960780B1 FR 1002404 A FR1002404 A FR 1002404A FR 1002404 A FR1002404 A FR 1002404A FR 2960780 B1 FR2960780 B1 FR 2960780B1
Authority
FR
France
Prior art keywords
parkinson
medicine
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1002404A
Other languages
English (en)
Other versions
FR2960780A1 (fr
Inventor
Andreas Hartmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR1002404A priority Critical patent/FR2960780B1/fr
Priority to PCT/IB2011/052460 priority patent/WO2011154887A1/fr
Publication of FR2960780A1 publication Critical patent/FR2960780A1/fr
Application granted granted Critical
Publication of FR2960780B1 publication Critical patent/FR2960780B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1002404A 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson Active FR2960780B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1002404A FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson
PCT/IB2011/052460 WO2011154887A1 (fr) 2010-06-07 2011-06-06 Méllitine pour son utilisation dans le traitement de la maladie de parkinson

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1002404A FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson

Publications (2)

Publication Number Publication Date
FR2960780A1 FR2960780A1 (fr) 2011-12-09
FR2960780B1 true FR2960780B1 (fr) 2012-08-10

Family

ID=42635109

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1002404A Active FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson

Country Status (1)

Country Link
FR (1) FR2960780B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013083574A1 (fr) * 2011-12-05 2013-06-13 Key Neurosciences Sas Composition pour traiter la maladie de parkinson

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918282B1 (fr) * 2007-07-02 2009-10-02 Assistance Publique Hopitaux P Medicament pour le traitement de la maladie de parkinson
FR2918281B1 (fr) * 2007-09-25 2009-11-06 Assist Publ Hopitaux De Paris Medicament pour le traitement de la maladie de parkinson.

Also Published As

Publication number Publication date
FR2960780A1 (fr) 2011-12-09

Similar Documents

Publication Publication Date Title
EP2683382A4 (fr) Régimes posologiques pour le traitement de la maladie de fabry
EP2911664A4 (fr) Polythérapies pour le traitement de la maladie d'alzheimer et des troubles associés
EP2665479A4 (fr) Procédés et produits médicamenteux destinés au traitement de la maladie d'alzheimer
JP2015501783A5 (fr)
EP2542255A4 (fr) Méthodes et compositions pour le traitement de la maladie de degos
EP2601948A4 (fr) Préparation pour le traitement d'une lésion de moelle épinière
EP2651407A4 (fr) 3-méthanesulfonylpropionitrile pour le traitement d'une inflammation et de la douleur
EP2844279A4 (fr) Schéma posologique pour le traitement de la maladie de pompe
EP2773779A4 (fr) Méthodes et compositions pour le diagnostic, le pronostic et le traitement d'états neurologiques
IL216399A0 (en) Pharmaceutical composition for the treatment of heart diseases
EP2528603A4 (fr) Compositions pharmaceutiques pour le traitement de la douleur et d'autres indications
EP2579867A4 (fr) Régime à base de triheptanoïne pour le traitement de la maladie des corps de polyglucosane de l'adulte (apbd)
EP2552417A4 (fr) Formulations pharmaceutiques pour le traitement de vessie hyperactive
EP2421367A4 (fr) Administration d'allantoïne pour le traitement d'une maladie neurodégénérative et d'un traumatisme neurologique
EP2978446A4 (fr) Procédés et agents pour le traitement de la maladie d'alzheimer
IL261742B (en) Human antibodies and their diagnostic and therapeutic uses for the treatment of neurological diseases
EP2678009A4 (fr) Analogues de cystamine pour le traitement de la maladie de parkinson
EP2959903A4 (fr) Médicament pour le traitement de maladie des yeux
IL260078B (en) Therapy used to treat Gaucher disease
EP2676665A4 (fr) Utilisation de la mangostine- dans la préparation de médicaments destinés à traiter la maladie d'alzheimer
EP2477656A4 (fr) Traitement d'affections neurologiques
EP2660600A4 (fr) Médicament de diagnostic et procédé de diagnostic pour la maladie d'alzheimer
EP2900259A4 (fr) Schéma posologique de glycosidase pour le traitement d'une maladie infectieuse
EP2819741A4 (fr) Implants de médicaments solides pour l'administration intracochléaire d'agents thérapeutiques pour le traitement de troubles otiques
EP2802319A4 (fr) Polythérapie à base de doses fixes pour le traitement de la maladie de parkinson

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

CL Concession to grant licences

Name of requester: KEY NEUROSCIENCES, FR

Effective date: 20160322

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8